TrialInvestigational new drugs2012

Sorafenib in patients with metastatic gastrointestinal stromal tumors who failed two or more prior tyrosine kinase inhibitors: a phase II study of Korean gastrointestinal stromal tumors study group.

S H Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.